Mutations in RPL3L and MYZAP increase risk of atrial fibrillation
Rósa B. Þórólfsdóttir, Garðar Sveinbjörnsson, Patrick Sulem, Stefan Jonsson, Gisli Hreinn Halldorsson, Páll Melsted, Erna V. Ivarsdottir, Olafur B. Davidsson, Ragnar P. Kristjansson, Guðmar Þorleifsson, Anna Helgadóttir, Sólveig Grétarsdóttir, Gudmundur Logi Norddahl, Sridharan Rajamani, Bjarni Torfason, , Kāri Stefánsson
This study identifies mutations in RPL3L and MYZAP as risk factors for atrial fibrillation through genome-wide association analysis and functional validation.
bioRxiv · Nov 21, 2017 · PreprintGenetics